Thus far, administration of N'5-or C14-labeled uric acid precursors to patients with primary gout has revealed an unequivocal metabolic aberration (namely, grossly increased total uric acid-N'5 or -C14) only in some cases (3) (4) (5) (6) (7) (8) , estimated to represent roughly 30 per cent of the gouty population (9) . This group of gouty subjects is further characterized by greatly enhanced uric acid excretion while maintaining enlarged uric acid pools-clear evidence of production of uric acid considerably in excess of the normal. In the remaining gouty subjects studied, apparently representative of the majority of cases of primary gout, the available isotope data either reveal lesser increases in utilization of isotope-labeled precursors for uric acid biosynthesis, manifest only when appropriate corrections are made for enlarged uric acid pools and increased uric acid excretion into the gut (10) , or fail to disclose any distinct metabolic abnormality whatever.
In the isotope studies made to date, measurements have been limited almost exclusively to total uric acid-N15 or -C14; i.e., the mean isotope enrichment of all four nitrogens or all five carbons, collectively, of the uric acid molecule. The present study extends such measurements to analysis of the intramolecular distribution of uric acid-N'5, and explores further the possibility of abnormal distribution of isotope within the uric acid molecule even when the total uric acid isotope abundance approximates that found in nongouty subjects. Dissection of the uric acid molecule in this way can be particularly revealing in gout now that the sequential enzymatic reactions effecting placement of each atom in purine biosynthesis are securely established (11) . * This work was supported in part by a grant-in-aid (A-162) from the National Institute of Arthritis and Metabolic Diseases. Preliminary reports of some of the results appear elsewhere as abstracts (1, 2) .
f Fellow, American Heart Association.
Data on the intramolecular distribution of the isotope incorporated into uric acid in normal man were recorded in one subject given glycine-N15 by Shemin and Rittenberg (12) who found that most of the uric acid-N15 appeared at N-7 but that a substantial proportion, increasing from 23 per cent on day 1 to 41 per cent on day 14, was present also in the remaining nitrogens, 1, 3, and 9 ( Figure 1 ). 1 The predominant N'5 enrichment of N-7 indicated that glycine contributes N-7 (and C-4 and C-5) of the uric acid molecule ( Figure  1 ), by a reaction now known to combine intact glycine with 5-phosphoribosyl-1-amine to form glycinamide ribonucleotide (11) . The N15 enrichment of the three remaining nitrogen atoms implied that appreciable quantities of nitrogen derived from glycine are utilized in normal man to provide N-9 and N-3 by way of the amide nitrogen of glutamine, and N-1 through the amino nitrogen of aspartic acid (11) (Figure 1 ).
Recent studies with glycine-1-C14-N'5 suggest that these latter more indirect metabolic pathways for utilization of glycine nitrogen-i.e., involving other than direct incorporation of intact glycinemay be of even greater quantitative importance in uric acid formation in gout (8) . When glycine-1-C'4-N'5 was administered to two gouty uric acid "overexcretors," not only was incorporation of both N15 and C14 greater than normal but the N'5/C'4 ratios obtained ranged from about 2.0 to 3.0, as compared with normal ratios of 1.3 to 1.7 calculated from the data of Shemin and Rittenberg (12) 2 and 1.4 to 1.7 and 1.6 to 2.0 found in two nongouty subjects (8) . N15/C14 1 Seegmiller, Laster and Stetten (J. biol. Chem. 1955, 216 , 653) likewise demonstrated N"5-(7+9)/N15-(1+3) ratios of about 5 on the second day after glycine-N1' administration to two normal human subjects. ratios of 2.0 to 3.0 imply (8) that the disproportion between glycine nitrogen and glycine carbon utilized for purine biosynthesis in these gouty overexcretors was even greater than in normal man, because more of the nitrogen was incorporated into N-( 1 + 3 + 9), or recycled back into N-7, or both. The present analysis indicates that both of these processes are in fact operative.
Glycine-l-C14-N'5 has been given also to a gouty subject whose urinary uric acid excretion was within normal limits (8) . The uric acid-N'5 and -C'4 incorporation, too, appeared to be within the limits of normal variations, but the N15/C14 ratios again were high, approximating 2.0. In this instance, uric acid samples were degraded and N1-7 'and N15-(1 + 3 +9) separately determined. Increased initial N15-(_ 1+ 3 + 9)/total uric acid-N'5 ratios and high N'5-7/total C14 ratios suggested that in this gouty "normal excretor" too, more than normal glycine nitrogen was being diverted into pathways leading to N-9, N-3, and N-1, and recycled back into N-7.
The rather arbitrary classification of gouty subjects according to urinary uric acid output is based on the following criteria (8): gouty "overexcretors" are defined as those whose 24-hour urinary uric acid excretion on a basal diet exceeded our normal mean plus 3 SD (i.e., > 628 mg) ; those whose daily output was less are designated "normal excretors."
The present report includes data on the intramolecular distribution of uric acid-N'5 in four normal subjects, four gouty uric acid overexcretors and one additional gouty normal excretor, all
given glycine-N'5. Summarized also are data on uric acid-N'5 and its intramolecular distribution after administration of ammonium-N'5 chloride to two normal subjects, to three of the four gouty overexcretors given glycine-N'5 some years before, and to three gouty normal excretors of whom two had previously received glycine-N'5.
The objective in giving ammonium-N'5 chloride was to study incorporation of N15 into N-9 and N-3 of the uric acid molecule more directly, since ammonia nitrogen is rapidly and extensively utilized for the synthesis of glutamine (13) through the action of glutamic dehydrogenase and glutamine synthetase.
METHODS
Data on uric acid-N15 and uric acid-C14 after administration of glycine-C14-N' have been previously recorded (8) for gouty subjects C.W., P.C., H.G., and A.R., and nongouty subjects T.G. and L.C.; also the details of the clinical status and dietary regulation of these subj ects, the dosage of isotope-labeled glycine given, and the methods of isolation of uric acid from the urine and of measurements of specific activity. Similar procedures were followed in gouty subjects D.R. and I.S. and normal subjects L.B. and M.A., who were given glycine-N1' and are added to the present series. N'-7 and Nu-(1+3+9) were determined after acid hydrolysis of uric acid samples (14) .
Six gouty subjects (C.W., P.C., H.G., A.R., I.S., G.H.) were given a single oral dose of 6.5 g ammonium-N1" chloride (N'6 = 64 atom per cent excess), the approximate N"5 equivalent of the glycine-N1' dosage they had received 2 or 3 years before. For G.H., who weighed 127 kg, this dose was too low and he was therefore subsequently given 13.0 g ammonium-N1" chloride. Normal subjects R.W. and N.J. received 6.5 g ammonium-N11
chloride. Urinary uric acid samples were obtained under the same conditions as for the glycine-N" experiments (8) . In addition to Nu-7 and N"-(1+3+9) determinations (14) , N"-(1+3) and N1"-(7+9) were estimated after oxidation of uric acid samples with potassium chlorate in acid solution (14) . From the data so obtained the N'5 atom per cent excess of each of the four uric acid nitrogens could be calculated.
The daily urinary excretion of total nitrogen, urea nitrogen, ammonia (and the corresponding urinary total N15, urea-N15, and ammonium-N's), uric acid, and creatinine was measured by the methods previously employed (3, 4, 8) . In the gouty overexcretors, D.R., C.W., P.C., and H.G. (Table I, Figure 2 ), all of whom incorporated glycine-N'5 into uric acid in gross excess, the uric acid N15-7 atoms per cent excess rose to 0.5 to > 0.6 on day 1, as compared with about 0.13 to 0.19 in the normal subjects. The curves for N15 incorporation into N-7 closely paralleled throughout those for uric acid total N15 (Figure 2) .
More of the excess N15 appropriated from glycine-N'5 in these gouty overexcretors appeared in N-7 than in any other one uric acid nitrogen. N15-7 enrichment of this magnitude could hardly be accounted for plausibly by postulating a reduction in the free glycine metabolic pool in gouty subjects, particularly in view of the comparatively large glycine dose administered. It follows, therefore, that in such gouty overexcretors more than the normal quantity of intact glycine reacts directly with what must then be more than the normal quantity of 5-phosphoribosyl-1-amine; and evidence will be presented that more 5-phosphoribosyl-l-amine is in fact generated in these subjects.
About half of the excess N15 incorporated into uric acid in these cases appeared in the aggregate N'5-(1 + 3 + 9), although the mean N15 abundance of each of the three nitrogen atoms was relatively low compared with N15-7 (peaks at some 0.10 to 0.20 atom per cent excess). The curves for the composite over-all pattern for N15 incorporation into N-(1 + 3 + 9) did not vary much from those for uric acid total N15 ( Figure  2 ). In contrast to the nongouty subjects, this marked enrichment of N'5-(1 + 3 + 9) in the gouty overexcretors occurred even on day 1, with initial N15-(1 + 3 + 9)/total uric acid-N'5 ratios of 34, 47, 48, and 50 per cent as compared with 25, 29, 29 , and 34 per cent in the normal subjects (Table I ). The initial greater enrichment of N'5-(1 + 3 + 9) presumably results from fuller utilization of N15 derived from glycine-N'5 by the action of such enzymes as glycine oxidase, serine dehydrase, transaminases. (To attempt to account for these differences by postulating a substantial contraction of the endogenous metabolic nitrogen pool seems unwarranted in view of the specificity of the aberration in uric acid metabolism in primary gout.) If more than nor-627 Interestingly enough, in the gouty normal excretors A.R. and I.S., the intramolecular distribution of N15 also was abnormal: the ratios N15-(1 + 3 + 9)/total uric acid-N15 were high on day 1 (40 and 47 per cent, respectively) and remained high throughout. Thus, as in the overt gouty overexcretors, more than the normal proportion of nitrogen derived from degraded glycine was utilized for purine biosynthesis.
C. Uric acid N'5-7/C"4 ratios. The abnormally high N'5/C'4 ratios in patients with gout (8) , previously referred to, are accounted for in part by the demonstration of high N15-(1 + 3 + 9)/ uric acid total N15 ratios in such subjects. There remains, however, the possilbility that recycling of glycine-N'5 back into N-7 of the uric acid molecule might also be contributory. Recycling can be identified when glycine-1-C14-N'5 is administered, by establishing N'5-7/C"4 ratios > 1.0.3
In nongouty subjects T.G. and L.C., N15-7/ C14 ratios of 1.0 to 1.1 were the rule (Table  II) . In gouty overexcretors C.W. and H.G. and gouty normal excretor A.R., the N15-7/C"4 ratios were higher: 1.2 to 1.6, 1.2 to 1.5, and 1.0 to 1.3, respectively (Table II) . These results imply more recycling of labeled reconstituted glycine back into purine biosynthesis in gouty than in normal subjects, particularly after day 1.
In gouty overexcretor P.C., given glycine-2-C14-N", lower N"5-7/C14 ratios were found. varying from 0.7 on day 1 to 0.8 on days 4 and 5, and 1.0 on day 7. These lower ratios are consistent with the wider distribution within the uric acid molecule of the a-carbon of glycine, which contributes C-2 and C-8 as well as C-5.
Ammonium-N15 incorporation into uric acid
When ammonium-N15 chloride was given, the general pattern of day-by-day isotope incorporation into uric acid in both gouty and nongouty subjects was similar to that after glycine-N'5 administration, although in approximately equivalent N15 dosage the uric acid-N15 atom per cent excess was consistently lower (Table III, Figure   - 3The N15-7/C1' ratio would be unity if the carboxyl carbon of glycine-l-C" incorporated into uric acid appeared solely at C-4; actually, ratios slightly less than unity would be anticipated in view of weak specific activity found at C-6 and other carbon atoms. N"-7/C" ratios > 1.0 are generated as a result of recycling and direct incorporation of glycine which has been metabolized and reconstituted (16) . The higher ratios are a consequence, among other things, of the disparity in the magnitude of the metabolic nitrogen and carbon pools from which the constituents for resynthesis of glycine are drawn: presumably, N' derived from glycine-1-C"-N"5 has a smaller volume of distribution than C14, hence the donors of nitrogen to glycine resynthesis would be expected to retain a greater isotope abundance than the carbon donors. It has been established (17, 18) that the chief source of glycine in biosynthesis is serine, which is itself formed from hydroxypyruvate and (by way of phosphoserine) from 3-phosphohydroxypyruvate, with alanine and glutamic acid, respectively, chiefly contributing nitrogen by transamination. There is also, of course, rapid loss of C4 as C'402.
3). Significant N'5 enrichment was present on day 1, there was usually a demonstrable small peak in uric acid-N'5 atom per cent excess on day 2 or 3, and for some time thereafter a prolonged plateau, even in the gouty overexcretors in whom the decline in uric acid-N'5 abundance was less pronounced in the first week than after glycine-N'5 administration. In individual cases of gout there were, as will be noted subsequently, interesting differences in the abundance and intramolecular distribution of uric acid-N'5 after administration of ammonium-N'5 chloride, as compared with glycine-N'5. In gouty overexcretors C.W. and P.C. the uric acid-N'5 was three times normal: 0.11 atom per cent excess on day 1, and 0.13 on day 2, gradually declining thereafter. Gouty overexcretor H.G. incorporated less ammonium-N'5 than his counterparts: 0.057 atom per cent excess uric acid-N'5 on day 1, rising to a peak of 0.077. This is in contrast to H.G.'s excessive incorporation of glycine-N'5, which was greater than that of any of the other gouty overexcretors and out of proportion to the quantity of urinary uric acid he excreted daily. In C.W. the high uric acid-N15 after ammonium-N'5 chloride also was more consistent with his very high daily urinary uric acid output than after glycine-N'5, which yielded lower uric acid-N'5 figures than those found in any of the other gouty overexcretors.
(The day-to-day relative abundance of uric acid-N15 after glycine-N'5 as compared with that after ammonium-N'5 chloride averaged 3.8 for H.G., 1.6 for C.W., and 2.1 for P.C.) The cumulative urinary uric acid-N'5 incorporation at the end of the first week was 0.28 per cent of dose for C.W., 0.14 for P.C., and 0.11 for H.G.
Gouty normal excretor A.R. incorporated more ammonium-N'5 (0.051 atom per cent excess N15) into uric acid on day 1 than did the two normal subjects and he continued to do so over the period of observation; in fact his uric acid-N'5 curve approaches that of gouty overexcretor H.G. (Figure 3) . I.S., on the other hand, yielded uric acid-N'5 data within or slightly below the normal range, at least before correction for his expanded uric acid pool. (In A.R. the mean relative abundance of uric acid-N'5 after glycine-N15 as compared with that after ammonium-N'5 chloride was 1.6; in I.S. it was higher, 2.6; in both instances these ratios gradually rose, in contrast to the gradual decline in the ratios in the gouty overexcretors.) The cumulative urinary uric acid-N15 over the first week was 0.08 per cent of dose in A.R. and 0.05 in I.S.
Two experiments were conducted in gouty normal excretor G.H., who weighed 127 kg and whose uric acid pool was 3.0 g (serum uric acid 12.4 mg per 100 ml). In the first experiment 1.0 g Nl' was given as ammonium-N15 chloride; in the second, a few months later, twice this dosage was given. As shown in Table III , the uric acid-N'5 atom per cent excess throughout the second experiment was just about double that in the first. The percentage of N15 dose incorporated into urinary uric acid consequently remained relatively constant at 0.05 to 0.06. B. Uric acid N'5-(l + 3 + 9) and N15-7. As anticipated, more of the uric acid-N15 was found in N-(1 + 3 + 9) after administration of ammonium-N15 chloride than after glycine-N'5; consequently, N15-(1 + 3 + 9)/total uric acid-N15 ratios consistently were high. No clear distinction between gouty and nongouty subjects could be made in these ratios on day 1 (as was the case after glycine-N'5) or subsequently.
In normal subjects R.W. and N.J., N15-(1 + 3 + 9) was 0.035 and 0.045 atom per cent excess, respectively, on day 1 (69 and 83 per cent of the total uric acid-N15), rising somewhat subsequently (Table III, Figure 3 ) to continue at 80 to 86 per cent of the total uric acid-N'5.
In gouty overexcretors C.W. and P.C. the excessive incorporation of N15 into uric acid already noted was found to be the result chiefly of an abnormal N15-(l + 3 + 9) abundance, for the most part > 0.10 atom per cent excess N'5, constituting 83 to 89 per cent of the total uric acid-N15 throughout the first week. In gouty overexcretor H.G. the incorporation of N15 into N-(1 + 3 + 9) on day 1 (0.056 atom per cent excess, rising to a peak of 0.081 ) was less pronounced than in his fellows, hence the total uric acid-N'5 also was not so high; nevertheless, N15-(1 + 3 + 9) constituted 72 to 80 per cent of the total uric acid-N15 throughout the first week. In gouty normal excretors A.R., I.S., and G.H. the N'5 abundance of N-(1 + 3 + 9) varied in correspondence with their varied total uric acid-N15, of which, as in the others, it constituted by far the greatest part.
In contrast to glycine-N15, administration of ammonium-N15 chloride resulted in generally less N15 enrichment of N-7 than of any other nitrogen atom, and least of the large surplus of uric acid-N15 in gouty overexcretors could be ascribed to N"5-7, except perhaps in H.G. Nevertheless, in both nongouty and gouty subjects N-7 was labeled, presumably by recycling and incorporation of glycine, reconstituted chiefly from serine to which N15 was donated by transamination (19) . These processes seemed to be unusually proficient in H.G. after administration of ammonium-N'5 chloride, just as was apparent after the dose of glycine-N'5.
C. Distribution of N'5-(1 + 3 + 9) among N-9, N-3 and N-1. Nl5-9 was obtained by difference from N'5-(1+ 3 + 9) and N'5-(1+ 3), also by difference from N'5-(7 + 9) and N15-7. N15-3 was assumed to approximate N'5-9 (20) since both derive from glutamine amide-N", and on this assumption N15-1 could be calculated from N5-(1+ 3 + 9) and N'5-(l + 3).
In normal subject N.J. virtually all of N15-(1 + 3 + 9) was localized at N-9 and N-3 in the uric acid samples obtained on days 1 and 2; N15_ 1was too low to estimate. (This distribution corresponds to the results on day 0.5 in the pigeon fed ammonium-N15 cited in Reference 21). On day 3, N'5-9 and N15-3 began to decline and N15-1 to increase, presumably as a consequence of randomization of N15 by transamination. By day 7 the N15 abundance of all four uric acid nitrogens was approximately the same ( Figure  4) . In normal subject R.W. the intramolecularabundance and distribution of uric acid-N15 was similar except that randomization of N'5 occurred earlier, on day 1; consequently the initial figures for N15-9 and N15-3 were lower and those for N'5-1 higher than in N.J. The corresponding data in gouty overexcretor C.W. are shown in Figure 4 . The distribution of uric acid-N15 follows the same general sequence as in normal subject N.J. but at higher levels of isotope enrichment. Gouty overexcretor H.G. was anomalous, as already noted, in failing to show the early enrichment of N15-9 and N15-3 exhibited by the others. In gouty normal excretor A.R., N15 distribution curves were very similar to those of normal subject N.J. except at slightly but fairly consistently higher levels of isotope abundance.
3. Urinary excretion of ammonium-N'5 and urea-N'5 in gouty subjects
Excretion of ammonium in the urine was not perceptibly increased after a dose of 6.5 g of (iso- Compared with the flood of urea-N'5 in the urine on days 1 and 2, the output of uric acid-N'5, even in gouty overexcretors, was infinitesimal indeed. After glycine-N15 administration, the per cent dose excreted as uric acid-N'5 was about 1: 1,000 of that excreted as urea-N'5 in normal subjects, and about 3 to 5: 1,000 in gouty overexcretors. After ammonium-N'5 administration the proportion was even smaller-about 1.5: 10,-000 in normal subjects and of the order of 5:10,-000 in gouty overexcretors. Because the elimination of urea-N'5 dropped off sharply after day 3, whereas that of uric acid-N'5 continued for longer periods, the differences just cited were slightly less pronounced when calculated on the basis of cumulative output over the first week. Thus, after glycine-N'5 administration the ratios of per cent dose excreted as uric acid-N15: urea-N'5 were about 3: 1,000 for normal subjects and about 10 to 15: 1,000 for gouty overexcretors. After ammonium-N'5 administration the corresponding figures were 1: 1,000 and 2 to 4: 1,000, respectively. It is obvious that any deflection of urinary nitrogen from urea to uric acid would be apparent in at least some cases of gout when uric acid nitrogen excretion is measured but would be imperceptible in measurements of urea nitrogen.
DISCUSSION
Despite the minute proportion of administered glycine-N15 or ammonium-N15 incorporated as N15 INCORPORATION INTO URIC ACID uric acid-N15 in man, and the number of intermediates and pools of intermediates intervening in biosynthesis, meaningful patterns of incorporation evidently can be obtained not only for total uric acid-N15 but also for the intramolecular distribution of the isotope. As indicated under Results, analysis of these patterns makes it possible to infer the metabolic pathways by which these precursors are utilized for uric acid biosynthesis in normal and gouty subjects, and to discern additional differences between the gouty and nongouty.
The most striking and consistent deviations from the normal were found in gouty overexcretors of uric acid. Whether given glycine-N'5 or ammonium-N15, the abundance of uric acid-N15 in these subjects invariably was in substantial excess of the normal. After glycine-N15 administration more of the excess uric acid-N'5 was found in N-7 than in any other one nitrogen atom, due in part to direct incorporation of more glycine-N15 from the comparatively small diluent glycine pool and in part to recycling of reconstituted glycine relatively rich in N15. However, almost half of the total uric acid-N15 appeared at N-(1 + 3 + 9) from day 1 on-significantly more than initial N1"-(1 + 3 + 9)/uric acid-N15 ratios in the normal; this indicates rapid transfer and abnormally large utilization at these sites of nitrogen derived from degraded glycine. After ammonium-N1" was given, the bulk of the excess uric acid-N15 in gouty overexcretors appeared initially at N-9 and N-3. With subsequent randomization of N15 by transamination, the isotope was more uniformly distributed among the four nitrogens of the uric acid molecule, for the first week still in greater than normal abundance.
In the gouty normal excretors given glycine-N15, the total uric acid-N'5 appeared to be within the limits of normal variation (before correction for exchange with their larger uric acid pools) but, like the gouty overexcretors, N15-(1 + 3 + 9) was disproportionately high on day 1 as compared with the normal. After administration of ammonium-N'5 the uric acid-N15 abundance in the several cases in this category varied: greater than normal, within normal limits, and apparently even less than normal, before correction for exchange with their larger uric acid pools and for possible differences in metabolic nitrogen pools. As in the other subjects studied, the N15 abundance of N-9 and N-3 initially was greater than at N-7 or N-1, but the isotope subsequently was more uniformly distributed among the four uric acid nitrogen atoms.
In the course of the study isolated metabolic variations were noted in certain individuals; for example, in the utilization of intact glycine-N"5 in Patient H.G. and in the duration of sequestration of ammonium-N'5 as glutamine-N15 in others.
In any one subject, however, the patterns of isotope incorporation into uric acid showed rather remarkable regularity. The broad implications of these patterns merit comment.
When the abnormally high uric acid-N15 of gouty overexcretors given glycine-N15 was first discovered, it was-suggested that "an unusually large uricotelic component" might be responsible for the implied overproduction of uric acid (3) ; that the inborn error of (primary) gout constitutes a metabolic derangement in which "a disproportionate quantity of simple nitrogen and carbon precursors of uric acid is diverted from the main metabolic channels culminating in urea and carbon dioxide formation to pathways leading to urate formation" (24) . The present report offers additional data in support of a diversion of precursor amino acid nitrogen (and by inference also carbon precursors) to de novo uric acid biosynthesis and implicates some of the specific reactions involved in increased uric acid formation, which is obvious in some cases but only inferential in others. In secondary gout, such diversion of purine precursors and overproduction of uric acid clearly is a consequence of the aggressive demands of exaggerated hemopoiesis for nucleic acid formation (25, 26) . In primary gout, however, the basic causes are still obscure. It may be assumed that the diversion of precursors to uric acid biosynthesis is not due to genetic transmittal of a supranormal complement of enzymes for purine biosynthesis but, as in other inborn errors of metabolism, is related to deficiency of one or another enzyme. As pointed out elsewhere (27) the only derangements in uric acid biosynthesis per se thus far disclosed in gout seem to involve fuller utilization of precursors by the normal metabolic pathways of purine biosynthesis, and this appears to be the result of one or more as yet undefined and apparently relatively minor errors in the disposition of amino acid nitrogen. 4 The crux of the problem of overproduction of uric acid in primary gout, it is suggested, centers in the reasons why, with equal loads of precursor amino acids-whether free or combined as protein (28)-the gouty subject tends to deliver excessive quantities of nitrogenous substrate to the enzymes which initiate and presumably set the pace for de novo uric acid biosynthesis. This is indicated by the initial, disproportionate N15 abundance of N-(1 + 3 + 9), i.e., N-9, particularly when glycine-N15 is administered, and by what appears to be a parallel increase in turnover of 5-phosphoribosylpyrophosphate in gouty subjects recently reported by Wyngaarden, Jones and Ashton (29) . The initial reactions in question are the irreversible transfer of the amide nitrogen of glutamine to 5-phosphoribosylpyrophosphate by the action of phosphoribosylpyrophosphate amidotransferase, and the ensuing union of 5-phosphoribosylamine so formed with glycine to give glycinamide ribonucleotide (11) . Also participating may be an alternative initial reaction recently described by Nierlich and Magasanik (30) , in which ribose-5-phosphate, ammonia, and adenosine triphosphate combine directly to form 5-phosphoribosylamine and, when glycine is present, glycinamide ribonucleotide.
More than the normal quantity of precursor amino acid nitrogen may be made available to the initiating mechanisms of de novo uric acid biosynthesis in primary gout as a consequence of default of other pathways competing for utilization of these amino acids (27) . In this view the essential causes of overproduction of uric acid should be sought in deficiencies of one or more enzymes involved in the metabolism of certain amino acids and the broad spectrum of urea and glycine-N'5 or ammonium-N'5. The gouty normal excretors did not have unequivocally greater than normal uric acid-N15 abundance after glycine-N15 administration unless a correction was made for their expanded uric acid pools. After ammonium-N15 administration, the uric acid-N'5 abundance was somewhat greater than normal in two gouty normal excretors even without such correction.
After administration of glycine-N'5, N-7 was enriched more than any other one uric acid nitrogen in both gouty and nongouty subjects. However, more of the total uric acid-N'5 appeared initially at N-(1 + 3 + 9) in the gouty (normal as well as overexcretors) than in the nongouty. Thus the gouty subjects uniformly utilized more glycine nitrogen for uric acid biosynthesis, not only directly as intact glycine and after recycling of reconstituted glycine (N-7), but also after transfer of glycine nitrogen to the amide nitrogen of glutamine (N-9,3) and the amino nitrogen of aspartic acid (N-1).
After administration of ammonium-N15, most of the uric acid-N'5 appeared initially at N-(9 + 3) in both gouty and nongouty subjectsin gross excess in the gouty overexcretors, however, and in somewhat greater than normal abun-dance (even before correction for expanded uric acid pools) in the one gouty normal excretor so studied. With subsequent randomization of N15, presumably by transamination, the distribution of isotope among the four uric acid nitrogens became more uniform.
There appear to be differences between gouty and normal man in respect to the utilization of precursor amino acids, nitrogen being diverted in the gouty from competing pathways to the sequential reactions of de novo uric acid biosynthesis. Given the same load of amino acid precursors, whether free or combined as dietary protein, the gouty subject apparently makes available to the enzymes initiating de novo uric acid biosynthesis more substrate than does normal man; this results in pronounced overproduction of uric acid in some instances, less pronounced or inferential overproduction in others. It is suggested that the underlying inborn metabolic error in primary gout, at least in some cases, may be an innate deficiency of one or more enzymes concerned with the disposition of amino acid nitrogen by metabolic pathways in competition with de novo uric acid biosynthesis.
